BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18654347)

  • 1. Targeted delivery of magnetic aerosol droplets to the lung.
    Dames P; Gleich B; Flemmer A; Hajek K; Seidl N; Wiekhorst F; Eberbeck D; Bittmann I; Bergemann C; Weyh T; Trahms L; Rosenecker J; Rudolph C
    Nat Nanotechnol; 2007 Aug; 2(8):495-9. PubMed ID: 18654347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine: magnetic nanoparticles hit the target.
    Amirfazli A
    Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols.
    Rudolph C; Gleich B; Flemmer AW
    Methods Mol Biol; 2010; 624():267-80. PubMed ID: 20217602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomagnetosols: magnetism opens up new perspectives for targeted aerosol delivery to the lung.
    Plank C
    Trends Biotechnol; 2008 Feb; 26(2):59-63. PubMed ID: 18191261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
    Martin AR; Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guiding aerosol deposition in the lung.
    Coates AL
    N Engl J Med; 2008 Jan; 358(3):304-5. PubMed ID: 18199871
    [No Abstract]   [Full Text] [Related]  

  • 8. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
    Tewes F; Ehrhardt C; Healy AM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer.
    Tseng CL; Wu SY; Wang WH; Peng CL; Lin FH; Lin CC; Young TH; Shieh MJ
    Biomaterials; 2008 Jul; 29(20):3014-22. PubMed ID: 18436301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of multifunctional magnetic nanoparticles.
    McCarthy JR; Kelly KA; Sun EY; Weissleder R
    Nanomedicine (Lond); 2007 Apr; 2(2):153-67. PubMed ID: 17716118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.
    Qi A; Friend JR; Yeo LY; Morton DA; McIntosh MP; Spiccia L
    Lab Chip; 2009 Aug; 9(15):2184-93. PubMed ID: 19606295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled delivery of aerosolized cyclosporine.
    Corcoran TE
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1119-27. PubMed ID: 16997418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.